Stem Cell Treatment for Kidney Failure Cost in India

The average cost of stem cell treatment for kidney failure in India ranges from $4,000 to $8,000. This pricing offers an affordable alternative to Western countries without compromising care quality.

Success rates vary based on patient condition, but many experience improved kidney function and delayed need for dialysis. Stem cells help regenerate damaged renal tissues effectively.

Yes, it is generally safe when performed by certified professionals. India follows strict medical protocols, utilizing autologous or screened allogeneic cells to minimize rejection and side effects.

The actual stem cell administration usually takes a few hours. However, international patients should plan to stay in India for 10 to 14 days for thorough evaluations, treatment, and follow-up care.

Specialists in India typically use mesenchymal stem cells (MSCs) harvested from the patient's own bone marrow or adipose (fat) tissue, ensuring high compatibility and reducing rejection risks.

While not a complete replacement for dialysis in end-stage renal disease, stem cell therapy can significantly improve kidney function, reduce dialysis frequency, and enhance overall quality of life.

Ideal candidates are patients in early to moderate stages of chronic kidney disease. A comprehensive medical evaluation in India is required to determine if stem cell therapy will be beneficial.

Recovery is typically quick, with most patients resuming light activities within a few days. Gradual improvements in kidney function markers are usually observed over the following three to six months.

Yes, stem cell procedures are regulated by the Indian Council of Medical Research (ICMR). Approved therapies follow strict safety and ethical guidelines to protect all international patients.

The duration of benefits varies by individual, but many patients experience sustained improvements for several years. Healthy lifestyle choices and proper medical management help prolong the results.

Stem cells are typically administered through a minimally invasive intravenous (IV) drip or targeted renal artery injection. This allows the cells to migrate directly to the damaged kidney tissues.

Comprehensive packages in India generally include pre-treatment medical evaluations, the stem cell harvesting and administration, doctor consultations, airport transfers, and post-procedure monitoring.